44BAI Registry

Index

SearchChatHubDashboardLabsModelsProvidersBenchmarksEvaluationsLibraryPatentsGraphResourcesIncidents44B RegistryForum
Patents
Prev·Next

AMPLICON PASSENGERS AS IMMUNE-ONCOLOGY TARGETS

Patent №

US 12,518,878

Granted

2026-01-06

Filed 2023

Owner

Cornell University

Lab

—

AI components

0

Assignment

None on record

Dataset

AIPD

Application

18123025

View graph

Methods for identifying oncogene amplicon-encoded cell surface proteins in a subject and preparing adoptive immunotherapies directed to cell surface proteins.

G16H 50/20G16B 45/00G16B 40/20G16B 30/00
Google Patents

Ownership

Cornell University

From the same owner

NEUROMORPHIC ALGORITHM FOR RAPID ONLINE LEARNING AND SIGNAL RESTORATIONUS 12,664,408 · 2026CLASSIFYING BIOMEDICAL ACOUSTICS BASED ON IMAGE REPRESENTATIONUS 12,629,100 · 2026QUANTUM COMPUTING BASED DEEP LEARNING FOR DETECTION, DIAGNOSIS AND OTHER APPLICATIONSUS 12,566,987 · 2026SCALABLE CONTROL OF HEAT PUMPS WITH LIMITED SMART-HOME DEVICESUS 12,553,634 · 2026RAPID GENERATION OF CUSTOM-FIT GARMENT PATTERNS FROM 3D BODY SCANSUS 12,555,341 · 2026RAPID PROTOTYPING AND IN VITRO MODELING OF PATIENT-SPECIFIC CORONARY ARTERY BYPASS GRAFTSUS 12,527,895 · 2026DEVICES, SYSTEMS, AND METHODS FOR PERSONAL SPEECH RECOGNITION AND REPLACEMENTUS 12,505,842 · 2025DARC EXPRESSION AS PROGNOSTICATOR OF IMMUNOTHERAPY OUTCOMESUS 12,398,428 · 2025

Full text

Google Patents

© 2026 NYSGPT2525 LLC
44B

Welcome.

This panel sticks with you. Pick anything below and it opens right beside it, so you can dig through 60,000-plus records without ever losing your spot here.

Travel 44B

LibraryPapers, policy, standards, statuteLabsEvery organization building AIModelsIntelligence, price, and speedBenchmarksThe evaluation catalogIncidentsAI failures and harmsSearchOne field across everythingDashboardThe state of AI accountability in NY44B RegistryThe Art. 44-B compliance portal